[pp.int.general] Copenhagen, our turn to dive into
Reinier Bakels
r.bakels at planet.nl
Wed Dec 9 16:07:54 CET 2009
> Patents are one of the main issues concerning the transfer of
> technologies to the "2nd and 3rd world" countries in order to fight
> climate change. Even if most of the press focuses on the $$$ transfert
> question, it is in fact in two parts: the 10 billions $/year for the
> developed countries to pay, and the techs that have to be transfered.
>
> i really think we should all voice loud about that, it is the due time.
>
> A few elements i have already gathered:
>
> - only 2,15% of the patents at the WiPO concern environment.
> - That figure isn't growing.
> - it's covered under the TRIPS
> http://www.wto.org/english/tratop_e/trips_e/trips_e.htm
> - french official report covering the subject (in French)
> http://www.strategie.gouv.fr/article.php3?id_article=1081
>
I hear contracdictory signals. First the rumor was that e.g. China was not
prepared to agree with CO2 reduction plans because it would force them to
pay zillions of $ to the US manufacturers of climate "adaptation and
mitigation" technologies, but later an expert told me that really the
developed world is (formally) obliged to pay.
I was at a WIPO conference in Geneva in July where a man from General
Electric explained that his bosses were *only* iteressed in "the bottom
line" ("no compassion" - never seeen an American businessman before
explaining that he did not bother about ethics!). All presentations plus
audio are on the WIPO website.
Part of the confusion is that many of the "climate" technologies are not
patented at all PLUS that lesser developed countries don't just need the
technology - BUT "capacity building" which includes e.g. education of local
people.
During a recent conference, I heard an interesting conversation between a
scholar who was working on patents & climate and another working on patents
& pharma. The latter expressed to be envious of the former: in pharma it is
a complete mess, with patents as a major roadblock for innovation (yes,
unbelievable!) BUT the climate problem has the "advantage" of being
relatively new PLUS there is a true "sense of urgency" that may help true
breakthoughs =- in line with pirate desires.
We may *die* because pharma developers spend more time to litigation than to
research, but we should not *drown* because the same mistakes are made
again in the climate field.
reinier
More information about the pp.international.general
mailing list